Ashley Hartmann Kline's most recent trade in Palvella Therapeutics Inc. was a trade of 111,496 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on May 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Palvella Therapeutics Inc. | Ashley Hartmann Kline | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 111,496 | 111,496 | - | - | Non-Qualified Stock Option (right to buy) | |
| Palvella Therapeutics Inc. | Ashley Hartmann Kline | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 17,436 | 17,436 | - | - | Incentive Stock Option (right to buy) |